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ABSTRACT
Maternal environmental factors can impact on the phenotype of the offspring via the induction of
epigenetic adaptive mechanisms. The advanced fetal programming hypothesis proposes that maternal
genetic variants may inﬂuence the offspring’s phenotype indirectly via epigenetic modiﬁcation, despite
the absence of a primary genetic defect. To test this hypothesis, heterozygous female eNOS knockout
mice and wild type mice were bred with male wild type mice. We then assessed the impact of maternal
eNOS deﬁciency on the liver phenotype of wild type offspring. Birth weight of male wild type offspring
born to female heterozygous eNOS knockout mice was reduced compared to offspring of wild type mice.
Moreover, the offspring displayed a sex speciﬁc liver phenotype, with an increased liver weight, due to
steatosis. This was accompanied by sex speciﬁc differences in expression and DNA methylation of distinct
genes. Liver global DNA methylation was signiﬁcantly enhanced in both male and female offspring. Also,
hepatic parameters of carbohydrate metabolism were reduced in male and female offspring. In addition,
male mice displayed reductions in various amino acids in the liver. Maternal genetic alterations, such as
partial deletion of the eNOS gene, can affect liver metabolism of wild type offspring without transmission
of the intrinsic defect. This occurs in a sex speciﬁc way, with more detrimental effects in females. This
ﬁnding demonstrates that a maternal genetic defect can epigenetically alter the phenotype of the
offspring, without inheritance of the defect itself. Importantly, these acquired epigenetic phenotypic
changes can persist into adulthood.
Abbreviations: CML, carboxmethyllysin; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide syn-
thase; IUGR, intrauterine growth retardation; LC-MS-MS, liquid chromatography tandem mass spectrometry; MeDIP,
methylated DNA immunoprecipitation; miRNA, microRNA; wt, wild type.
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Introduction
The ‘fetal origin’ hypothesis proposes that adulthood cardio-
vascular and metabolic diseases originate through adaptation
of the fetus to environmental conditions in early life.1 It was
proposed that an event in a critical early period of life leads
to sustained alterations of organ structure and function in
response to environmental factors. Such events may result in
cardiovascular and metabolic diseases in later life. The classi-
cal event resulting in fetal programming is maternal undernu-
trition during pregnancy. This was ﬁrst recognized in
epidemiological studies and later conﬁrmed in animal
experiments.1-4 Meanwhile, several other mechanisms caused
by environmental conditions in early life leading to lifelong
functional and structural alterations have been described,
including glucocorticoid exposure of the fetus due to 11b-
hydroxysteroid dehydrogenase deﬁciency of the placenta5,6 or
a high protein diet during pregnancy.7 Another mechanism
responsible for programming events during intrauterine life
might be related to maternal genes affecting the fetal pheno-
type independently of the fetal DNA-based genome. The ﬁrst
example is described for Drosophila wimp mutation, inﬂuenc-
ing the offspring’s lethal phenotype, even when the mutation
CONTACT Berthold Hocher hocher@uni-potsdam.de; Department of Basic Medicine, Medical College of Hunan Normal University, Changsha, China.
*These authors contributed equally to this work.
Supplemental data for this article can be accessed on the publisher’s website.
Published with license by Taylor & Francis Group, LLC © Berthold Hocher, Hannah Haumann, Jan Rahnenf€ohrer, Christoph Reichetzeder, Philipp Kalk, Thiemo Pfab, Oleg Tsuprykov, Stefan Winter,
Ute Hofmann, Jian Li, Gerhard P. P€oschel, Florian Lang, Detlef Schuppan, Matthias Schwab, and Elke Schaeffeler.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unre-
stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
EPIGENETICS
2016, VOL. 11, NO. 7, 539–552
http://dx.doi.org/10.1080/15592294.2016.1184800
is not inherited.8 Our group was the ﬁrst to translate this to
mammals/humans by demonstrating that genetic variation of
a maternal gene most likely involved in the control of blood
supply to the uterus was associated with a substantial reduc-
tion of offspring birth weight without being actually transmit-
ted to the offspring.9,10 Other independent association studies
in humans likewise suggest that certain maternal genes may
affect the fetal phenotype even without transmission of that
particular gene to the fetus.11,12 In other words, a gene of a
human individual may inﬂuence the physiology of another
subject without being present in this particular individual.13
Plausibly, interaction of one organism with the metabolism
of another of the same species is seen in mammals mainly
during pregnancy, where the placenta serves as interface
between both individuals.13
To prove that maternal genes indeed can affect the off-
spring’s phenotype, as suggested by association studies (see
above), we bred female heterozygous endothelial nitric oxide
synthase (eNOS) knockout mice with male wild type (wt)
mice and compared their wild type offspring with offspring
from wild type mice. We have chosen eNOS knockout mice
to test this hypothesis, because eNOS—like the genetic varia-
tions analyzed in our initial association study in
humans9,10—plays a pivotal role in the control of vascular
and also placental function,14-17 and heterozygous eNOS
deﬁciency has been shown to create an unfavorable intra-
uterine environment inﬂuencing the vascular phenotype in
offspring, independently of its genetic transmission.18 We
reasoned that the resultant endothelial and vascular dysfunc-
tion could also impact central parameters of metabolism as
reﬂected by fatty liver disease. An illustration of the underly-
ing hypothesis of this study is provided in Fig. 1.
Results
Phenotype of wt mice born to heterozygous eNOS
knockout mothers and wt fathers
First, we veriﬁed that offspring born to heterozygous eNOS
knockout (eNOSC/¡) mothers and wt fathers were wild type
with respect to eNOS expression. Gene and protein expression
of eNOS and inducible nitric oxide synthase (iNOS) in liver tis-
sue were not altered in male and female wt animals born to
eNOSC/¡mothers (Fig. 2 A, B; Supplementary Table S1).
Birth Weight, Growth, and Organ Weight
Male wt mice born to eNOSC/¡ mothers and wt fathers had a
signiﬁcantly lower birth weight when compared to wt male
mice born to wt mothers and wt fathers (1.27 § 0.05 g vs.
1.47 § 0.05 g, P D 0.004), whereas birth weight of female
offspring did not differ signiﬁcantly [1.26 § 0.05 g (wt father,
eNOSC/¡ mother) vs. 1.35 § 0.04 g (wt father, wt mother);
Supplementary Fig. S1].
Body weight of male offspring of wt fathers and heterozy-
gous eNOS knockout mothers remained signiﬁcantly lower
during the ﬁrst days of life (Supplementary Fig. S2). Thereaf-
ter, no signiﬁcant differences in body weight were noticed
(Supplementary Fig. S3). At study end at week 24, male mice
born to eNOSC/¡ mothers and wt fathers had a signiﬁcantly
lower body weight when compared to male offspring born to
wt mothers and fathers (Supplementary Table S2). Female
offspring born to eNOSC/¡ mothers and wt fathers showed
signiﬁcantly higher body weights than controls starting on
day 12 after birth and remaining elevated throughout most
of life thereafter (Supplementary Figs. S4 and S5, Supple-
mentary Table S2). Heart weight was signiﬁcantly higher in
female offspring born to eNOSC/¡ mothers and wt fathers
compared to female wt offspring born to wt mothers and
fathers (Supplementary Table S2). Relative lung and kidney
weights did not differ signiﬁcantly (Supplementary
Table S2). Relative liver weight was not different in female
offspring born to eNOSC/¡ mothers and wt fathers as com-
pared to the control group (Table 1).
Blood pressure, heart rate, GFR, and fasting glucose
Blood pressure and heart rate were similar in all groups. More-
over, glomerular ﬁltration rate (GFR) at study end did not dif-
fer signiﬁcantly between groups. Fasting glucose was
numerically lower in wt mice born to heterozygous eNOS
knockout mothers. This effect was signiﬁcant, however, only in
week 21 (Supplementary Table S2).
Characterization of the liver phenotype
First we assessed the liver morphology. Diameter of liver
lobules, liver glycogen concentration, and the connective tissue
content were not affected by maternal eNOS genotype (Table 1).
However, fat content and density of lipid droplets were signiﬁ-
cantly higher in female wt mice born to eNOSC/¡ mothers and
wt fathers compared to wt mice born to wt mothers and wt
fathers (P < 0.001, see Table 1 and Fig. 3A-C). Examination of
lipid droplet size showed a signiﬁcant increase of droplets in
female wt offspring of wt fathers and eNOSC/¡ mothers, but a
non-signiﬁcant decrease in male animals (Fig. 3D, E). The
mean area of lipid droplets in these animals was 5.2 mm2, and
5.6% of droplets were bigger than 25 mm2. These numbers
were signiﬁcantly lower in wt female offspring from wt fathers
and wt mothers, with 2.1 mm2 and 0.6%, respectively. None of
the groups showed any signiﬁcant lobular inﬂammation or an
increase in the number of CD68-positive cells (macrophages)
(Table 1).
To extend characterization of the liver phenotype, selected
marker proteins related to oxidative stress and hyperglycemia
were analyzed by Western blot. Female but not male wt off-
spring with eNOSC/¡mothers and wt fathers had a signiﬁcantly
higher hepatic amount of carboxymethyllysine (CML) (P <
0.01, Fig. 4A). Nitrotyrosine-modiﬁed proteins were enhanced
in female offspring from eNOSC/¡ mother, but failed to attain
statistical signiﬁcance (Fig. 4B).
Moreover, selected substrates of glucose metabolism were
analyzed in liver tissue by quantitative LC-MS-MS technol-
ogy. Fumarate concentration was reduced in male and female
wt offspring born to eNOSC/¡ mothers and wt fathers. Male
offspring showed signiﬁcantly lower concentrations of glu-
cose 6-phosphate and fructose 6-phosphate, whereas hepatic
fructose 1,6-bisphosphate content was reduced in female
mice (Fig. 4 C-F, Supplementary Table S3). Analysis of liver
amino acid concentrations revealed that male but not female
wt offspring born to eNOSC/¡ mothers and wt fathers had
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signiﬁcantly lower concentration of several, mainly essential
amino acids when compared to offspring born to wt mothers
and wt fathers (Table 2).
Mechanisms of phenotypic alteration in wt mice born to
eNOSC/¡mothers
Characterization of the mouse transcriptome
Genome-wide microarray analyses were performed for pooled
liver RNA samples of randomly selected mice (n D 30). This
approach was complemented by independent RT-PCR based
investigation of mRNA transcripts and miRNAs using samples
of the total mouse cohort.
Microarray analysis revealed 11,628 and 12,047 genes dif-
ferentially expressed between male and female offspring of
eNOSC/¡ and wt mothers, respectively (Fig. 5 A, B). Six
genes showed P-values  0.001 in our analyses. Of these, 5
genes (Amy2a5, Clps, Cpa1, Ctrbl, and 2210010C04 Riken
cDNA/trypsinogen 7) showed higher expression in female off-
spring from eNOSC/¡ mothers and wt fathers than in female
Figure 1. The advanced fetal programming hypothesis. The ‘fetal origin’ hypothesis proposes that adulthood cardiovascular, metabolic, and mental diseases originate
through adaptation of the fetus to environmental conditions in early life. We proposed that maternal genetic defects might impact on the offspring phenotype via geno-
mic-epigenomic interactions, without transmittance of the defective gene. Such interactions, here exempliﬁed by the eNOS gene, could be mediated during 3 phases of
reproduction (A-C). (A) Maternal gene dysfunction can alter ovary function: eNOS mediates physiological ovarian functions, such as blood ﬂow and angiogenesis and is
involved in oocyte meiotic maturation.49,50 (B) Maternal gene dysfunction can alter placental and uterine function: eNOS plays a pivotal role in the control of placental
function, and eNOS deﬁciency is associated with an unfavorable intrauterine environment.16,17 (C) Maternal gene dysfunction may alter weaning behavior and lactation
performance: eNOS is involved in behavioral processes and elicits regulatory functions in lactation.51,52 Alterations in maternal eNOS function thus may affect the offspring
in the early postnatal phase.51,52 (D) The impact of maternal gene dysfunction on embryonal/fetal/neonatal environmental factors listed in A-C may trigger stable, long
lasting epigenetic adaptation in the offspring.53-55 Epigenetic mechanisms encompass DNA methylation, non-coding RNAs, and chromatin modiﬁcations.56 (E) Epigenetic
modiﬁcation, speciﬁcally DNA methylation and non-coding RNAs, can result in permanently altered gene expression in the offspring.34 On a global scale, both DNA hyper-
methylation and DNA hypomethylation may cause genomic instability.57,58 (F) Altered gene expression and genomic instability triggered by epigenetic maladaptation can
impact on the offspring phenotype by permanently altering organ structure and function.59,60
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offspring from wt mothers and wt fathers, with fold changes
(FC) ranging from 2.54 to 4. In addition, Csad showed lower
expression (FC D 0.4) in male offspring from eNOSC/¡
mothers and wt fathers than in male offspring from wt
mothers and wt fathers. Next, we performed gene set enrich-
ment analyses (GSEA) based on Gene Ontology (GO; gen-
eontology.org) terms. Similar to the single gene analyses,
more signiﬁcantly enriched gene sets were detected for
female compared to male offspring, where terms with per-
mutation P  0.0001 were only revealed for female mice
(Supplementary Files 1 and 2). In particular, considering the
biological process domain of GO the top enriched GO terms
(permutation P  0.0001) comprised the term ‘metabolic
process’ and its child nodes (Supplementary File 3).
Based on these data, we performed a hypothesis driven
approach by analyzing genes potentially involved in liver metab-
olism and the pathogenesis of fatty liver disease (Supplementary
Table S1), since this was the key phenotype in female offspring
born to eNOSC/¡ mothers. Male wt offspring of eNOSC/¡ moth-
ers and wt fathers expressed signiﬁcant lower levels of PPARg
and Csad when compared to offspring born to wt mothers and
wt fathers. The expression levels of Igf2 and Igf-binding protein
2 (Igf-BP2) were signiﬁcantly increased. Female wt offspring
from eNOSC/¡ mothers and wt fathers expressed signiﬁcantly
lower levels of Srebf1c and signiﬁcantly higher levels of Fitm1
and Cdkn1a gene compared to offspring born to wt mothers
and wt fathers (Fig. 6 A, B, Supplementary Table S1).
Liver fat ratio correlated signiﬁcantly with Fitm1 expression
(Fig. 6C) in female (correlation coefﬁcient D 0.520) and male
(correlation coefﬁcient D 0.476) mice.
Finally, we analyzed the expression levels of selected miRNA
implicated in liver metabolism and obesity. For instance, miR-
122 and miR-33 regulate hepatic lipid metabolism by inﬂuenc-
ing the expression of several genes implicated in fatty acid
synthesis or oxidation.19 Male, but not female, wt offspring
from eNOSC/¡ mothers and wt fathers expressed signiﬁcantly
more miR-370 (P < 0.05, Fig. 7A,B) when compared to wt
offspring born to wt mothers and wt fathers.
However, some of the microarray data could not be con-
ﬁrmed by qRT-PCR [Supplementary Table S4; although the
same transcripts were quantiﬁed (Supplementary Table S5)] in
the total mouse cohort. These discrepancies were most likely
Figure 2. Hepatic eNOS and iNOS protein content in wt offspring. Hepatic eNOS (A) and iNOS (B) protein content analyzed by Western blot (empty bar, wt father / wt
mother; gray bar, wt father / eNOSC/¡ mother ).
Table 1. Offspring liver weight, morphology, and glycogen content.
Offspring of both sexes Male offspring Female offspring
WT (F:WT; M:WT) WT (F:WT; M:eNOS KO) WT (F:WT; M:WT) WT (F:WT; M: eNOS KO) WT (F:WT; M:WT) WT (F:WT; M: eNOS KO)
N 35-48 30-35 21-22 15-18 24-27 17-18
Absolute Liver Weight (g) 1.19 § 0.05 1.20 § 0.04 1.56§ 0.05 1.40 § 0.04 0.90 § 0.02 1.00 § 0.03$
Relative Liver Weight (% of
body weight)
4.31§ 0.06 4.41 § 0.06 4.56§ 0.07 4.59 § 0.10 4.11 § 0.08 4.23§ 0.06
Lobular Dimension (mm) 0.07 § 0.001 0.07 § 0.001 0.07 § 0.001 0.07 § 0.001 0.07 § 0.002 0.07§ 0.001
Connective Tissue Content (%
area)
0.16§ 0.02 0.12 § 0.02 0.12§ 0.03 0.12 § 0.02 0.18 § 0.03 0.12§ 0.03
Glycogen (mg/g liver) 14.09 § 1.02 16.44 § 1.54 13.31 § 1.46 17.32 § 1.83 14.93 § 1.44 15.67 § 2.54
Fat Content (% area) 2.06 § 0.26 4.33 § 0.82 1.85§ 0.36 1.23 § 0.29 2.25 § 0.37 6.92 § 1.18 C
Lipid Droplet Density
(droplets/mm2)
2701.0 § 411.2 5014.6 § 732.9 $ 2537.7 § 779.2 1699.3 § 416.8 2850.8 § 352.1 7777.3 § 864.1 C
N 13 15 7 7 6 8
Lobular Inﬂammation (score) 0.31 § 0.13 0.53 § 0.13 0.29§ 0.18 0.57 § 0.20 0.33 § 0.21 0.50§ 0.19
Number of CD68-Positive
Immune Cells (score)
0.85§ 0.10 0.87 § 0.09 0.86§ 0.14 0.86 § 0.14 0.83 § 0.17 0.88§ 0.13
F: Father, M: Mother, WT: wild type, eNOS KO: heterozygous eNOS knockout, $ P< 0.05 vs. WT (F:WT;M:WT), # P< 0.01 vs. WT (F:WT;M:WT), C P< 0.001 vs. WT (F:WT;M:WT)
542 B. HOCHER ET AL.
caused by gene expression outliers in single animals, distorting
the signals in the pooled samples used for microarrays.
Characterization of epigenetic factors
To investigate if epigenetic mechanisms contributed to phe-
notypic differences, global DNA methylation levels were
determined in liver tissue by LC-MS-MS analysis. Signiﬁ-
cantly higher content of 5-methylcytosine was found in
female and male wt offspring born to eNOSC/¡ mothers
and wt fathers (Fig. 8A). Correlation of liver fat content
with DNA methylation in female and male (Fig. 8B) wt off-
spring revealed a signiﬁcant correlation in female mice (cor-
relation coefﬁcient D 0.533), whereas in male mice there
was no correlation (correlation coefﬁcient D ¡0.158). The
expression of the Fitm1 gene correlated signiﬁcantly with
total liver DNA methylation in female (correlation coefﬁ-
cient D 0.369) but not in male offspring (correlation coefﬁ-
cient D ¡0.047) (Fig. 8C). Next, we performed speciﬁc
DNA methylation of the candidate gene Fitm1 by MeDIP
analysis. DNA methylation revealed signiﬁcant lower meth-
ylation of Fitm1 gene exon 1 in female wt offspring of
eNOSC/¡ mother and wt father (P < 0.05, Fig. 9) compared
to wt offspring born to wt mothers. Moreover, DNA meth-
ylation of a CpG island of another candidate gene (Cdkn1a)
was signiﬁcantly increased in female wt offspring from
eNOSC/¡ mothers (P < 0.01, Fig. 10).
Discussion
This study was designed to test the advanced fetal programming
hypothesis (Fig. 1) stating that maternal genes may affect the
fetal phenotype independently of transmission of the gene to
the fetus.9-12 To test this hypothesis, we bred female heterozy-
gous eNOS knockout mice with male wild type mice and com-
pared the phenotype of their wild type offspring to the
phenotype of offspring with wild type parents. We have chosen
eNOS knockout mice to test this hypothesis because eNOS plays
a pivotal role in placental function.14-17 The unfavorable intra-
uterine environment due to reduced maternal eNOS expression
has been shown to induce endothelial dysfunction in the off-
spring, independently of genetic transmission.18 Therefore, we
performed an initial screening to identify organs that are
affected by the advanced fetal programming process. This analy-
sis revealed that the liver is, in particular, affected by maternal
heterozygous eNOS deﬁciency in female wild type offspring,
whereas other organs, such as kidney and heart, seem to be less
affected. In the next step, we performed a detailed analysis using
morphological and biochemical techniques as well as liver
Figure 3. Lipid deposition in wt offspring liver tissue. (A) Liver sections of wt male and female offspring from wt father and wt mother (wt/wt) and wt father and hetero-
zygous eNOS knockout mother (wt/eNOSC/¡), determination of lipid content (B) and lipid droplet density (C) in liver tissue and size distributions of lipid droplets for
female (D) and male (E) wt offspring (empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother; C P < 0.001 vs. wt father / wt mother).
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metabolomics to get a thorough understanding of the resulting
liver phenotype and underlying molecular mechanisms.
Our study revealed that female offspring born to eNOSC/¡
deﬁcient female mice developed an increased absolute liver
weight, liver fat accumulation, and reduced liver concentrations
of fructose 1,6-bisphosphate and fumarate (Figs. 3 and 4). Male
offspring born to eNOSC/¡ female mice had a reduced birth
weight (Table 1). Liver concentrations of glucose 6-phosphate,
fructose 6-phosphate, and fumarate were reduced (Fig. 4). The
concentration of various amino acids (for example, tryptophan,
valine, leucine, isoleucine, threonine, phenylalanine) was like-
wise reduced in the liver of male mice born to female eNOSC/¡
mice (Table 2). In contrast to female offspring, liver fat accu-
mulation was not affected in male offspring (Fig. 3).
The amount of methylated cytosine as percentage of total
cytosine was signiﬁcantly increased in wild type offspring born
to female heterozygous eNOS knockout mice (Fig. 8A). Total
liver DNA methylation was signiﬁcantly related to liver fat
accumulation in female offspring—the main phenotypic ﬁnd-
ing in our study (Fig. 8B).
Nitric oxide (NO) is involved in the local regulation of vas-
cular resistance, promotes angiogenesis, and is a potential regu-
lator of placental steroid biosynthesis and glucose uptake.14
Therefore, deﬁciency of eNOS is related to the development of
intrauterine growth retardation (IUGR).20 It may promote the
development of hypoxia due to reduced uterine blood ﬂow and
placental oxygenation in pregnant mice, thereby restricting
nutrient transport capacity and fetal growth.15-17 This
Figure 4. Effects of maternal eNOS deﬁciency on hepatic protein content and metabolomics in wt offspring. Hepatic content of (A) carboxymethyllysine (CML) and
(B) nitrotyrosine (NT) modiﬁed proteins (relative expression) as well as (C) fumarate, (D) glucose 6-phosphate, (E) fructose 6-phosphate, and (F) fructose 1,6-
bisphosphate concentration (nmol/mg protein) (empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother; # P < 0.01 vs. wt father / wt mother; C
P < 0.001 vs. wt father / wt mother).
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Table 2. Amino acid concentration in offspring liver tissue.
Offspring of both sexes Male offspring Female offspring
WT (F:WT; M:WT) WT (F:WT; M:eNOS KO) WT (F:WT; M:WT) WT (F:WT; M:eNOS KO) WT (F:WT; M:WT) WT (F:WT; M:eNOS KO)
N 48-50 30-36 21-22 15-18 27-28 15-18
Alanine 38.26 § 1.42 37.37 § 1.70 35.89 § 1.63 34.57 § 2.72 40.12 § 2.14 40.18 § 1.88
Glycine 19.97 § 0.45 18.73 § 0.63 21.02 § 0.64 19.25 § 0.81 19.15 § 0.59 18.12 § 0.96
Urea 18.77 § 0.64 18.23 § 0.69 19.28 § 1.05 18.93 § 0.81 18.37 § 0.79 17.53 § 1.13
Valine 3.50 § 0.11 3.07§ 0.12 C 3.62 § 0.13 2.84 § 0.15 C 3.41 § 0.17 3.31§ 0.18
Leucine 4.24 § 0.14 3.65§ 0.19 C 4.57 § 0.20 3.26 § 0.20 C 3.97 § 0.17 4.03§ 0.29
Isoleucine 1.90 § 0.07 1.59§ 0.07 C 2.02 § 0.08 1.44 § 0.08 C 1.80 § 0.10 1.74§ 0.10
Proline 2.92 § 0.16 2.70§ 0.16 2.72 § 0.15 2.54 § 0.24 3.07 § 0.27 2.86§ 0.22
Methionine 1.31 § 0.04 1.14§ 0.06 # 1.36 § 0.07 0.99 § 0.06 C 1.28 § 0.05 1.29§ 0.09
Serine 4.89 § 0.19 4.42§ 0.20 $ 5.00 § 0.26 4.14 § 0.25 $ 4.81 § 0.27 4.72§ 0.30
Threonine 3.11 § 0.08 2.69§ 0.13 C 3.31 § 0.13 2.40 § 0.14 C 2.96 § 0.09 2.98§ 0.19
Phenylalanine 1.70 § 0.05 1.45§ 0.08 C 1.82 § 0.09 1.26 § 0.08 C 1.61 § 0.06 1.64§ 0.13
Aspartic acid 3.16 § 0.19 2.92§ 0.11 2.97 § 0.11 2.82 § 0.16 3.30 § 0.33 3.04§ 0.14
Cysteine 0.26 § 0.01 0.25§ 0.03 # 0.26 § 0.01 0.20 § 0.01 C 0.25 § 0.01 0.30§ 0.07
Glutamic acid 8.63 § 0.47 8.59§ 0.51 8.13 § 0.38 8.06 § 0.72 9.02 § 0.78 9.12§ 0.71
Lysine 7.16 § 0.35 6.38§ 0.38 6.96 § 0.50 5.56 § 0.47 7.32 § 0.49 7.19§ 0.53
Glutamine 23.46 § 1.16 20.16 § 1.00 25.65 § 1.40 21.68 § 1.34 21.74 § 1.72 19.55 § 1.48
Arginine 1.22 § 0.06 1.25§ 0.11 1.07 § 0.06 1.01 § 0.09 1.35 § 0.10 1.48§ 0.19
Histidine 4.50 § 0.13 3.78§ 0.14 C 4.84 § 0.17 3.71 § 0.23 C 4.23 § 0.18 3.84§ 0.17
Tyrosine 1.82 § 0.05 1.60§ 0.07 # 1.92 § 0.08 1.40 § 0.08 C 1.75 § 0.06 1.80§ 0.10
Tryptophan 0.50 § 0.01 0.41§ 0.02 C 0.49 § 0.01 0.35 § 0.02 C 0.51 § 0.02 0.47§ 0.02
Concentration of aminoacids expressed as nmol/mg protein. F: Father, M: Mother, WT: Wild type, eNOS KO: heterozygous eNOS knockout, $ P< 0.05 vs. WT (F:WT;M:WT), #
P < 0.01 vs. WT (F:WT;M:WT), C P < 0.001 vs. WT (F:WT;M:WT)
Figure 5. Gene expression in wt offspring. Manhattan plots displaying P-values from differential expression analyses between offspring from wt mothers and wt fathers
vs. offspring of eNOSC/¡ mothers and wt fathers. Analyses were conducted separately in (A) male and (B) female offspring. Genes with P < 0.001 are labeled.
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hypothesis is supported by earlier studies showing that the
unfavorable intrauterine environment due to diminished
maternal eNOS expression can promote endothelial
dysfunction in the offspring, independently of genetic trans-
mission.18 Embryonic development is very sensitive to even
moderate hypoxia. Hence, maternal heterozygous eNOS
Figure 6. Gene expression in wt offspring. Gene expression (fold expression compared to reference group) was analyzed by real time PCR of (A) male and (B) female wt
offspring. (C) Correlation of hepatic Fitm1 gene expression and liver fat content (empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother; $ P < 0.05 vs.
wt father / wt mother; # P < 0.01 vs. wt father / wt mother; C P < 0.001 vs. wt father / wt mother).
Figure 7. micoRNA expression in wt offspring. MicroRNA (miRNA) expression of selected miRNAs in (A) male and (B) female wt offspring.
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deﬁciency may be causal, because of the crucial role of eNOS in
placental function,14-17 which may contribute to fetal tissue
hypoxia similar to offspring of mice with complete lack of
eNOS (eNOS-/- mice),
21 which develop hypertension, and renal
and cardiac dysfunction in adult life.
In view of the support with relatively hypoxygenated blood
via the portal vein, the liver is particularly vulnerable during
hypoxia, and fatty liver is a common complication, for instance,
in obstructive sleep apnea.22 Decreased oxygen availability trig-
gers the switch from mitochondrial oxidative phosphorylation
to anaerobic glycolysis and affects lipid metabolism and accu-
mulation, generally reducing oxygen consumption while main-
taining ATP production.23 Continuous (even mild) placental
hypoxia in heterozygous eNOS knockout mothers together
with the alterations of placental hormone synthesis due to also
mild NO deﬁciency may lead to epigenetic alterations in
growing offspring and increases the sensibility of offspring to
metabolic dysfunction in later life, such as the development of
a phenotype similar to non-alcoholic fatty liver disease.24 These
alterations of placental microcirculation together with the alter-
ation of placental hormone synthesis might cause alterations in
the activity of key enzymes involved in the regulation of DNA
methylation. DNA methylation together with other epigenetic
mechanisms is a key factor of organ development and differen-
tiation in early life. Thus, any NO-related alterations of this
tightly regulated differentiation process during early life might
affect organ function in later life. However, it is unclear so far
why the offspring liver seems to be particularly vulnerable to
these NO effects in the placenta. Moreover, early postnatal
mechanisms might play a role as well, since the offspring was
not adopted by foster mothers; it is also possible that the
observed effects could be due to the postnatal environment
Figure 8. Global DNA methylation in wt offspring. Liver DNA methylation (in % of methylated to total cytosine residues) in (A) male and female wt offspring as well as
correlation of liver DNA methylation with (B) liver fat content (in % of red oil positive area in liver tissue) and (C) hepatic Fitm1 gene expression in female and male wt off-
spring (empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother; $ P < 0.05 vs. wt father / wt mother; #: P < 0.01 vs. wt father / wt mother).
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(amount or quality of the milk in the heterozygous eNOS
knockout mice or way of nursing of heterozygous eNOS knock-
out mice). Moreover, maternal heterozygous eNOS deﬁciency
might also affect the maturation of the genetically normal
oocytes in the maternal ovary (Fig. 1).
We demonstrated differences in total and gene speciﬁc DNA
methylation, hepatic fat accumulation and expression of dis-
tinct candidate genes of wild type offspring born to heterozy-
gous eNOS knockout mothers and wild type fathers and a clear
correlation of DNA methylation and hepatic fat accumulation
in female offspring (Fig. 8B). Genes involved in hepatic lipid
metabolism or mitochondrial activity do not contribute to the
observed lipid accumulation in female offspring (Fig. 6B, Sup-
plementary Table S1). Changes of lipid content may also be
related to alteration in hepatic lipid accumulation, inﬂux or
export.25 Fat storage inducing transmembrane protein (FITM)
1 belongs to a recently identiﬁed family of proteins of the endo-
plasmic reticulum that induce lipid droplet accumulation, while
it is not involved in triglyceride biosynthesis. FITM proteins are
regulated by PPAR a and g and their upregulation leads to
accumulation of lipid droplets.26 Fitm1 gene showed altered
DNA methylation in the intragenic region of exon 1 in female
wild type offspring from eNOSC/¡ mother, which is in line with
the higher level of Fitm1 gene expression in these animals
Figure 9. MeDIP DNA methylation analysis of Fitm1 gene. (A) Genomic organiza-
tion of Fitm1 exon 1, putative transcription start site (TSS), and position of identi-
ﬁed CpG island. Ampliﬁed sequence is shown in detail (primer binding sites in
bold letters and analyzed CpG dinucleotides bold / underlined, TSS indicated with
C1), (B) degree of DNA methylation of Fitm1 exon 1 in liver tissue of wt offspring
(empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother; $ P <
0.05 vs. wt father / wt mother).
Figure 10. MeDIP DNA methylation analysis of Cdkn1a gene. (A) Genomic organi-
zation of the Cdkn1a gene showing ﬁrst exons, transcription start site (TSS), and
the position of identiﬁed CpG islands; ampliﬁed sequence of CpG island 4 is shown
in detail (primer binding sites in bold letters and analyzed CpG dinucleotides bold
/ underlined). (B) Degree of DNA methylation of CpG island 4 in liver tissue of wt
offspring (empty bar, wt father / wt mother; gray bar, wt father / eNOSC/¡ mother;
# P < 0.01 vs. wt father / wt mother).
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(Figs. 6B and 9). Brenet et al.27 showed that not only promoter
methylation status, but also DNA methylation of intragenic
regions, especially of the ﬁrst exon, inﬂuences gene expression.
Otherwise, there is no direct evidence that methylation of this
genomic region inﬂuences Fitm1 gene expression. The positive
correlation between Fitm1 gene expression and DNA methyla-
tion in female offspring suggests further effects of DNA methyl-
ation, with a possible indirect effect on repressor regions of the
Fitm1 gene (Fig. 8B).
Liver Cdkn1a expression was also increased in the wild type
offspring from female heterozygous eNOS knockout mice
(Fig. 6B), a factor previously described to be upregulated in
fatty liver.28,29 Bioinformatic analysis predicted Cdkn1a to be a
future epigenetic biomarker for obesity, susceptible for early
life changes in promoter methylation, through its implication
in cell cycle progression and adipogenesis and the high abun-
dance of CpG islands.30 We found differences in Cdkn1a DNA
methylation, but further studies are need to elucidate how CpG
island methylation inﬂuences Cdkn1a gene expression.
The observed decrease in Srebf1c expression could be due to
compensatory regulation to avoid further hepatic fat accumula-
tion. Similarly, Anavi et al.31 found that hepatic Srebf1c expres-
sion in rats is reduced after infusion of a lipid emulsion.
The observed differences in gene expression do not account
for all phenotypic alterations conditioned by maternal eNOSC/¡
deﬁciency. Microarray analysis of gene expression failed to
identify further promising candidates since subsequent RT-
PCR analyses revealed that most of these genes were not
equally altered in all animals (Supplementary Table S4). In line
with this, other studies of the transcriptome in animal models
of fetal programming showed that the most differently regu-
lated genes seem not to be related to the observed pheno-
type,32,33 indicating that our current understanding of the
cascade of biochemical alterations induced by early life stimuli,
such as maternal mild NO deﬁciency during pregnancy, is far
from being complete. In particular, we do not understand why
the resulting phenotype is different in male and female off-
spring, although the stimulus—mild NO deﬁciency—is the
same for female and male offspring. Sex differences in fetal pro-
gramming to the same stimuli, however, are broadly described.5
A general answer to this question might be the observation that
the timing of DNA methylation is different in males and
females during early life development and, moreover, male and
female sex steroid hormone synthesized by the fetus and the
placenta might also modulate the effects of mild NO deﬁciency
during pregnancy on epigenetic and phenotypic alterations in
the offspring in a gender-dependent manner.
In male wt offspring born to eNOSC/¡ mothers and wt
fathers, the liver tissue concentration of most amino acids
was slightly reduced, by about 30%. Exceptions were those
amino acids that are either directly involved in ammonia
metabolism (glutamic acid, glutamine, aspartic acid, argi-
nine) or gluconeogenesis (alanine, glycine, serine). The
reduction of the amino acid concentration closely parallels
the percent increase in liver glycogen content of these ani-
mals, indicating that the observed decrease might be due to
the way of calculating this parameter, since the liver amino
acid concentration was given as amount of amino acids per
gram wet weight.
We also analyzed the expression of miRNA related to lipid
homeostasis, but the observed differences did not explain the
hepatic phenotype in the offspring. In addition, other epige-
netic mechanisms such as histone modiﬁcation or further alter-
ations in miRNA expression could be involved.34 Thus,
epigenetic modiﬁcations of yet unknown genes might have
caused the observed differences in gene expression.
Fetal programming is a multifactorial process, and minor
differences in promoter methylation and expression of a large
number of genes may signiﬁcantly contribute to the observed
outcome. This complex scenario and the limitations of current
biomedical technologies explain—together with the above-
described reasons—why it has been impossible to describe all
epigenetic alterations induced by parental genetic or early life
parental nutritional stimuli in detail.
Our observations support the advanced fetal programming
hypothesis10,35 and propose a non-environmental mechanism
of fetal programming driven by altered parental gene function.
Maternal, and possibly also paternal, genes may inﬂuence the
epigenome of maturing sperm, oocyte, and later embryo/fetus
and alter the phenotype of the fetus in later life, independently
of the fetal genome.35 This hypothesis has major implications:
i) It breaks with the classical laws of inheritance. According to
classical genetics the phenotype of wild type offspring born to
wild type mothers or heterozygous eNOS knockout mice should
be identical, but this was not the case. By contrast, our study
showed that a parental gene affects the phenotype in the off-
spring without genetic transmission. ii) It suggests reassessing
one of the most important tools currently used to understand
gene function: murine transgenic or knockout animal models.
Results of this study indicate that genetically manipulated ani-
mal models may not only reﬂect causality between a certain
genetic alteration and a resulting phenotype. Altered gene func-
tion may additionally induce permanent epigenetic changes,
thus impacting the offspring phenotype even without transmit-
tance of the modiﬁed maternal or paternal gene.
Material and methods
Breeding protocol
The entire study protocol was approved by the animal welfare
comity of the state of Berlin, Germany. We used the eNOS knock-
out mice36 of the C57BL/6J strain and their wild type (wt) litter-
mate. The breeding procedure is described in Supplementary
Fig. S6. Female wt mice were crossbred with homozygous male
eNOS knockout mice. The resulting female heterozygous eNOS
knockout (eNOSC/¡) mice were then again crossed with wt male
mice. Only wt offspring of this breeding procedure (F2 generation,
see Supplementary Fig. S6) entered the study. These mice were
compared to wt mice resulting from crossing wt male and wt
female mice. Study design and experimental protocols were con-
ducted according to the local institutional guidelines for the care
and use of laboratory animals.
Study protocol
Male and female offspring were kept for 24 weeks and analyzed
separately. Body weight, length, and abdominal diameter of the
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F2 generation were measured daily until day 13; thereafter,
body weight was measured daily until day 40 and weekly there-
after until week 20 of the experiment. Blood pressure was mea-
sured using the tail cuff method at week 24, as previously
described.37 GFR was calculated from urine and plasma creati-
nine at week 23. Fasting glucose level was determined at study
week 13 and 21.
Histology
Liver tissue was stained with hematoxylin eosin to determine lobu-
lar dimensions and the extent of lobular inﬂammation as described
in supplementary methods. Red oil staining was done as described
elsewhere.38 For further details see Supplementarymethods.
Immunohistochemical staining
Liver sections were immunostained for CD68 protein as
described in Supplementary material. The number of CD68-
positive macrophages in the liver was quantiﬁed as described
previously.39
Liver glycogen content
Hepatic glycogen content was determined using the amyloglu-
cosidase method, as described previously.40 See Supplementary
material for further details.
Western blotting
Immunoblotting of liver proteins was examined as previously
described.37,41 For further details see Supplementary methods.
Determination of central carbon metabolites in liver tissue
Metabolite concentrations in liver tissue homogenate were
determined by gas chromatography-mass spectrometry (GC-
MS) analysis and liquid chromatography-tandem mass spec-
trometry (LC-MS-MS) as described previously42,43 with minor
modiﬁcations. Detailed method was described in Supplemen-
tary material.
Quantitative real time PCR
Determination of gene expression level with quantitative real
time PCR was performed as previously described.44 See Supple-
mentary methods for further details.
MeDIP assay
Immunoprecipitation of methylated genomic DNA (MeDIP
assay) was performed as described by Weber et al.45 with minor
modiﬁcations. Brieﬂy, liver DNA was sonicated and precipi-
tated with antibody against 5-methylcytosine. The amount of
methylated DNA was quantiﬁed with quantitative real time
PCR, comparing the appearance of speciﬁc DNA sequence in
the precipitated and input DNA. See Supplementary methods
for further details.
Microarray gene expression analysis and GSEA
High quality RNA samples from the liver of 9 male and female
offspring of wt fathers and wt mothers, as well as 6 male and
female wt offspring from wt fathers and eNOSC/¡ knockout
mothers were selected for gene expression proﬁling. Pooled
samples consisting of 3 samples each were analyzed using Affy-
metrix GeneChip Mouse Gene ST 1.0 arrays (Affymetrix, Santa
Clara, CA). Microarray data was pre-processed using the RMA
(Robust Multichip average)46 algorithm in Expression Console
1.1 software (Affymetrix). Only genes with signal intensities >
27 D 128 on minimum 2 out of the 5 arrays with male/female
mouse pools were further investigated. Differences in gene
expression levels between male and female mice with wt or
eNOSC/¡ mother were analyzed by package limma-3.8.247 of
statistical software R-2.13.0 (www.r-project.org). A P-value <
0.05 was considered to indicate a signiﬁcant difference. Man-
hattan plots were used to display P-values from limma analyses.
Based on the fold changes from limma analyses mentioned
above GSEA of GO terms was performed by Bioconductor
package clusterProﬁler_2.4.248 (www.bioconductor.org) for
female as well for male offspring. To be more precise, GSEA
was conducted separately for each of the 3 GO domains (bio-
logical process, cellular component, and molecular function)
using a minimal gene set size of 30 and 9999 permutations. To
assign probe set IDs of the Affymetrix array to GO terms for
GSEA, packages clusterProﬁler and mogene10sttranscriptclus-
ter.db _8.4.0 were ﬁrst applied to assign probe set IDs to Entrez
IDs (www.ncbi.nlm.nih.gov/gene) and, thereby, to GO terms. If
several probe set IDs were present for one Entrez ID, the result
(fold change) of the probe set showing the smallest P-value in
limma analysis was used as input for GSEA.
Quantiﬁcation of total DNA methylation
Five-methyl-2’-deoxycytidine content was determined by LC-
MS-MS analysis (details see Supplementary Material). Brieﬂy,
genomic DNA samples were hydrolyzed by treatment with
nuclease P1 and alkaline phosphatase. After hydrolysis, 2’-
deoxycytidine and 5-methyl-2’-deoxycytidine were measured
by LC-MS-MS analysis using the respective stable isotope-
labeled analogs [15N3]deoxycytidine and 5-[
2H3]methyl-deoxy-
cytidine as internal standards. DNA methylation status is given
as percentage of 5-methyl-2’-deoxycytidine content relative to
total cytosine residues.
Statistics
Statistical analysis was performed using IBM SPSS statistics,
version 19. All values are presented as mean § SEM unless
noticed differently. For all data Mann-Whitney-U test was per-
formed and a P-value < 0.05 was considered to indicate a sig-
niﬁcant difference.
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